Safety and Efficacy of Xalkori ROS1
Recruiting
- Conditions
- Non-small Cell Lung Cancer
- Registration Number
- NCT03375242
- Lead Sponsor
- Pfizer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria:<br><br> - patients with unresectable progressive/recurrent NSCLC who are naive to XALKORI and<br> whose tumor is ROS1 gene positive<br><br>Exclusion Criteria:<br><br> - Patients with past history of hypersensitivity to any of the ingredients of XALKORI
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of adverse drug reactions in this surveillance.
- Secondary Outcome Measures
Name Time Method Objective Response Rate (ORR)